Treating pediatric nonalcoholic fatty liver disease with cysteamine: is adiponectin the key?
J Pediatr
.
2012 Oct;161(4):579-81.
doi: 10.1016/j.jpeds.2012.05.052.
Epub 2012 Jun 26.
Authors
Stavra A Xanthakos
,
Rohit Kohli
PMID:
22738945
DOI:
10.1016/j.jpeds.2012.05.052
No abstract available
Publication types
Editorial
Comment
MeSH terms
Adiponectin / chemistry*
Cysteamine / pharmacology*
Humans
Protein Multimerization / drug effects*
Substances
Adiponectin
Cysteamine